December 16, 2011 — About 20% to 30% of cancer patients who have undergone chemotherapy and/or radiation treatment develop myelodysplastic syndrome (MDS); this represents a distinct form of the ...
Effectiveness of First-Line Management Strategies for Stage I Follicular Lymphoma: Analysis of the National LymphoCare Study Accurate determination of prognosis is critical for selection of ...
SAN FRANCISCO - A new risk model for myelodysplastic syndrome provides survival projections that apply to patients at any stage of the disease, researchers at The University of Texas M. D. Anderson ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results